Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Wah‐Kheong Chan, Kee Huat Chuah, Ruveena Bhavani Rajaram, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 3, pp. 197-213
Open Access | Times Cited: 201

Showing 1-25 of 201 citing articles:

Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes
Lindsey Wang, Nathan A. Berger, David C. Kaelber, et al.
Gastroenterology (2024) Vol. 167, Iss. 4, pp. 689-703
Open Access | Times Cited: 29
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e320-e350
Open Access | Times Cited: 15
Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Yoon-su Ha, Won Kim, Seungjin Kim
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 1
The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9084-9102
Open Access | Times Cited: 20
Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Obesity Pillars (2024) Vol. 10, pp. 100108-100108
Open Access | Times Cited: 11
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions
M H Miran Beygi, Salma Ahi, Samaneh Zolghadri, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2220-2220
Open Access | Times Cited: 9
Developmental Programming of the Fetal Immune System by Maternal Western-Style Diet: Mechanisms and Implications for Disease Pathways in the Offspring
Benjamin N. Nelson, Jacob E. Friedman
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5951-5951
Open Access | Times Cited: 7
The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes‐related and cancer outcomes
David R. Riley, Theresa Hydes, Gema Hernadez, et al.
Liver International (2024) Vol. 44, Iss. 10, pp. 2538-2550
Open Access | Times Cited: 7
Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy
Leslie W. Nelson, Matthew H. Lee, John W. Garrett, et al.
American Journal of Roentgenology (2024) Vol. 223, Iss. 6
Closed Access | Times Cited: 6
Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction
Ammara A Majeed, Amna Subhan Butt
World Journal of Hepatology (2025) Vol. 17, Iss. 1
Closed Access
The correlation between heavy metal ions in blood and metabolic dysfunction-associated steatotic liver disease from 1999 to 2018 based on NHANES data
Haijun Ma, Ju Zhao, Jian Xu
Frontiers in Public Health (2025) Vol. 12
Open Access
Esteatosis hepática evaluada por tomografía en una población adulta de Cali, Colombia
Jorge Esteban Izquierdo-Ordoñez, Daniel Mafla-Rodríguez, Valentina Blanco-Romero, et al.
Hepatología (2025) Vol. 6, Iss. 1, pp. 47-54
Closed Access
Correlation between family function and self-management abilities in patients with metabolic dysfunction-associated steatotic liver disease
Yueying Zhu, Ru Chen, Hang Han, et al.
Journal of Health Population and Nutrition (2025) Vol. 44, Iss. 1
Open Access
Magnesium Depletion Score and Mortality in Individuals with Metabolic Dysfunction Associated Steatotic Liver Disease over a Median Follow-Up of 26 Years
Lei Fan, Xiangzhu Zhu, Xinyuan Zhang, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 244-244
Open Access
Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management
Daniel Simancas‐Racines, Giuseppe Annunziata, Ludovica Verde, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access
Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
Fan Zhang, Longgen Liu, Wenjian Li
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access
Environmental exposures and the risk of hepatocellular carcinoma
Divya Rayapati, Katherine A. McGlynn, John D. Groopman, et al.
Hepatology Communications (2025) Vol. 9, Iss. 2
Closed Access
Correlation between metabolic dysfunction-associated steatotic liver disease and subclinical coronary atherosclerosis in eastern China
Guanghui Ma, Guohou Xu, Haixia Huang
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the “Bermuda” triangle of malnutrition-sarcopenia-frailty severely affecting prognosis
Marcello Dallio, Mario Romeo, Filadelfo Nardo, et al.
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Marcello Dallio, Mario Romeo, Filadelfo Nardo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 761-761
Open Access
Unlocking the therapeutic potential of canagliflozin in NAFLD: Insights into AMPK/SIRT1-mediated lipophagy
Nahla E. El‐Ashmawy, Ghada M. Al‐Ashmawy, Asmaa A. Kamel, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167666-167666
Closed Access
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
Mario Romeo, Marcello Dallio, Carmine Napolitano, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 252-252
Open Access
Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices
Pervej Alom Barbhuiya, Ameena Ahmed, Partha Dutta, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Closed Access
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease
Andrea Pasta, Elena Formisano, Francesco Calabrese, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 241-241
Open Access
Page 1 - Next Page

Scroll to top